Sagent Pharmaceuticals
Latest round
- Series B
Last raised
- Apr 2010
Total raised
- $153M
Investors
- 3
About Sagent Pharmaceuticals
Founded in 2007 and headquartered in Schaumburg, US, Sagent Pharmaceuticals develops and markets generic injectable drugs. The company was involved in a significant transaction in July 2016, when Nichi-Iko Pharmaceuticals agreed to acquire Sagent for USD 736 mn, with the deal expected to close in March 2017. Jeff Yordon and Peter Kaemmerer serve as the CEO of the company.Sagent Pharmaceuticals specializes in the development, manufacturing, and marketing of generic pharmaceuticals, particularly injectable products including vials, prefilled syringes, and premixed bags. These products encompass critical care, oncology, anesthetics, and anti-infective drugs, serving healthcare providers and systems across the United States and select international markets.Sagent Pharmaceuticals is focused on expanding its product portfolio and entering new markets. The company plans to launch several new injectable products, although specific release dates have not been disclosed. The company aims to strengthen its presence in both domestic and international markets, although specific geographic targets have not been specified.
Who invested in Sagent Pharmaceuticals
3 investors across 4 rounds
See all investors in Sagent Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sagent Pharmaceuticals
Who invested in Sagent Pharmaceuticals?
Sagent Pharmaceuticals has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sagent Pharmaceuticals raised?
Sagent Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Sagent Pharmaceuticals last raise money?
Sagent Pharmaceuticals's most recent round on record is a Series B, in Apr 2010.
What does Sagent Pharmaceuticals do?
Founded in 2007 and headquartered in Schaumburg, US, Sagent Pharmaceuticals develops and markets generic injectable drugs.
Where is Sagent Pharmaceuticals headquartered?
Sagent Pharmaceuticals is headquartered in Schaumburg, US.
Which VCs invest in companies like Sagent Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Sagent Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Sagent Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.